Campaign India Team
Apr 24, 2025

Havas invests in Ostro's AI platform

This investment in the AI-led platform will support Havas Health Network, boost Havas Creative and Media Networks, and refine the agency's media precision.

Image credit: 
jcomp/Freepik.com
Image credit: jcomp/Freepik.com

Havas has invested in Ostro, an AI-powered digital engagement platform for life sciences brands. This move gives the global advertising company access to the latter's technology for its global ecosystem and offers support for Havas Health Network's clientele. The ad network also plans to extend this access to Havas Creative and Media Networks' content workflows and omnichannel activations to achieve enhanced media precision.

American independent investment banking and financial services company Houlihan Lokey served as the advisor for the deal.

The investment represents the latest in a series of strategic moves by Havas. “By combining creativity with AI-powered intelligence, we are empowering clients to deliver relevant, personalised, and compliant experiences at scale,” said Donna Murphy, global CEO of Havas Health & Creative Networks.

Ostro claims that many of the top 10 global biopharma companies are its clients and its platform adoption is also accelerating across mid-sized pharma and emerging biotech organisations. According to a company press release, the platform supports engagement that adjusts to every phase in a patient's healthcare journey.

“Ostro was built to make healthcare engagement more intuitive and personalised. Partnering with Havas gives us a global platform to scale,” said Dr Chase Feiger, CEO & co-founder, Ostro.

Stating that the partnership of Ostro’s solutions and Havas’ brand expertise will help unlock new insights, modular content delivery, and optimised omnichannel performance, Yannick Bolloré, CEO and chairman of Havas, said, “We constantly seek technologies that create meaningful value for our clients. Ostro represents a leap forward in intelligent brand engagement, making this partnership a natural evolution of Havas’ Converged strategy."

Ostro's technology integrates into branded and unbranded healthcare providers (HCPs) and patient digital experiences, enabling agent-led personalised engagement. It also meets all the applicable regulatory compliances and standards. It enables organisations to connect with patients, caregivers and healthcare providers through digital channels.

“Ostro’s technology doesn’t respond with static one-size-fits-all content; it is context-enabled,” said Ahmed Elsayyad, president and co-founder, Ostro. 

The strategic investment by Havas has been part of the group’s €400 million investment in data, tech and AI over four years, as announced last year. As part of its global transformation strategy, the company had announced that it would strengthen its capabilities across media, creative, and health networks. Under this initaitive, it has been integrating AI into content creation, audience engagement, and performance measurement. This is being done by Havas across its agencies to automate workflows and improve targeting.

Source:
Campaign India

Related Articles

Just Published

6 hours ago

Why Zee5’s language-first bet may be its best yet

As India’s OTT battle intensifies, the streaming platform goes hyperlocal with tech-backed storytelling and tier-2 targeting.

9 hours ago

Cannes Lions, AI, and the integrity reckoning

The first ever Cannes Lions Grand Prix withdrawal for AI misuse signals a watershed moment, but is this just the beginning of a much bigger reckoning for marketing in the AI age?

11 hours ago

India isn’t a muse; it’s time to brand the maker

Global brands borrowed India’s craft. Sam & Andy’s founding partner claims that Indian creators must now reclaim the narrative—with better systems, sharper storytelling, and unapologetic ownership.